[Correlation between the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors and EGFR mutations in advanced squamous cell lung cancer].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Volumn 35, Issue 5, 2012, Pages 323-328

  Duan, Jian chun ^a   An, Tong tong ^b   Wu, Mei na ^b   Yang, L ^b   Bai, Hua ^b   Wang, Zhi jie ^b   Wang, Yu yan ^b   Zhuo, Ming lei ^b   Zhao, Jun ^b   Wang, Shu hang ^b   Wang, Jie ^b  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE;

ADULT; AGED; ARTICLE; DRUG ANTAGONISM; FEMALE; GENETICS; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; MUTATION; PATHOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84879492481     PISSN: 10010939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)